These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11156716)

  • 1. Rescue percutaneous coronary intervention using transradial arterial access with glycoprotein IIb/IIIa inhibitor eptifibatide therapy initiated post-fibrinolysis.
    Charlat ML
    J Invasive Cardiol; 2000 Dec; 12 Suppl D():13D-5D. PubMed ID: 11156716
    [No Abstract]   [Full Text] [Related]  

  • 2. Radial versus femoral access for rescue percutaneous coronary intervention with adjuvant glycoprotein IIb/IIIa inhibitor use.
    Kassam S; Cantor WJ; Patel D; Gilchrist IC; Winegard LD; Rea ME; Bowman KA; Chisholm RJ; Strauss BH
    Can J Cardiol; 2004 Dec; 20(14):1439-42. PubMed ID: 15614338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prompt use of integrilin (eptifibatide) for unstable angina/subendocardial myocardial infarction: abrupt resolution of chest discomfort marked by brief reperfusion arrhythmias and subsequent stabilization.
    Fireman AS
    J Invasive Cardiol; 2000 Dec; 12 Suppl D():3D-4D. PubMed ID: 11156712
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab.
    Coto H
    J Invasive Cardiol; 2000 Oct; 12(10):528-31. PubMed ID: 11022214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid dissolution of intracoronary thrombus with eptifibatide therapy in a patient with post-infarction angina.
    Runyon JP; Snavely DD
    J Invasive Cardiol; 2000 Dec; 12 Suppl D():5D-7D. PubMed ID: 11156713
    [No Abstract]   [Full Text] [Related]  

  • 6. Bolus-only glycoprotein IIb/IIIa inhibitor revisited.
    Agahtehrani A; Dangas GD
    J Invasive Cardiol; 2006 Nov; 18(11):527. PubMed ID: 17090814
    [No Abstract]   [Full Text] [Related]  

  • 7. Abciximab: a review and update for clinicians.
    Mazzaferri EL; Young JJ
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):609-18. PubMed ID: 18510478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of eptifibatide for treatment of severe dissections as a bail-out procedure.
    Latsch A; Suselbeck T; Muth N; Poerner T; Baumbach A; Pfleger S; Borggrefe M; Haase KK
    Int J Cardiol; 2004 Aug; 96(2):229-33. PubMed ID: 15262038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of low-molecular-weight heparin in percutaneous intervention.
    Curran MJ; Grines CL
    J Invasive Cardiol; 2000; 12 Suppl C():13C-17C. PubMed ID: 10762863
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effectiveness and safety of a catheterization laboratory-only eptifibatide dosing strategy in patients undergoing percutaneous coronary intervention.
    Gurm HS; Hosman C; Bates ER; Share D; Hansen BB;
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001880. PubMed ID: 25657314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheolytic therapy combined with intragraft abciximab for treatment in acute myocardial infarction.
    Vallakati A; Mastrine L; Ayzenberg S
    J Invasive Cardiol; 2013 Feb; 25(2):E33-5. PubMed ID: 23388236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.
    Montalescot G; Borentain M; Payot L; Collet JP; Thomas D
    JAMA; 2004 Jul; 292(3):362-6. PubMed ID: 15265852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
    Stone GW; Bertrand ME; Moses JW; Ohman EM; Lincoff AM; Ware JH; Pocock SJ; McLaurin BT; Cox DA; Jafar MZ; Chandna H; Hartmann F; Leisch F; Strasser RH; Desaga M; Stuckey TD; Zelman RB; Lieber IH; Cohen DJ; Mehran R; White HD;
    JAMA; 2007 Feb; 297(6):591-602. PubMed ID: 17299194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eptifibatide and risk of bleeding after failed thrombolysis.
    Ali A; Rehan A; Ganji J; Munir A; Moser L; Davis T; Khan S; Lalonde T; Schreiber T
    J Invasive Cardiol; 2004 Jan; 16(1):20-2. PubMed ID: 14699218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant use of eptifibatide and enoxaparin in the medical management of a patient with a non-ST segment elevation acute coronary syndrome and in-stent restenosis.
    Nahlawi M; Benzuly K; Fintel D
    J Invasive Cardiol; 2000 Dec; 12 Suppl D():16D-8D. PubMed ID: 11156717
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of transradial vs. transfemoral approach in the treatment of acute myocardial infarction with primary angioplasty and abciximab.
    Philippe F; Larrazet F; Meziane T; Dibie A
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):67-73. PubMed ID: 14696162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
    ten Berg JM; van 't Hof AW; Dill T; Heestermans T; van Werkum JW; Mosterd A; van Houwelingen G; Koopmans PC; Stella PR; Boersma E; Hamm C;
    J Am Coll Cardiol; 2010 Jun; 55(22):2446-55. PubMed ID: 20510211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytopenia in acute coronary syndromes: etiologies and proposed management.
    Sharma A; Ferguson C; Bainey KR
    Can J Cardiol; 2015 Jun; 31(6):809-11. PubMed ID: 25913474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.
    Gibson CM; Cohen DJ; Cohen EA; Lui HK; Murphy SA; Marble SJ; Kitt M; Lorenz T; Tcheng JE
    Am J Cardiol; 2001 Jun; 87(11):1293-5. PubMed ID: 11377359
    [No Abstract]   [Full Text] [Related]  

  • 20. Does abciximab provide long-term benefit for patients with acute myocardial infarction treated with stents?
    Neumann FJ
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):190-1. PubMed ID: 16568126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.